האמט פי 250IU FVIII 600IU VWF
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FACTOR VIII (HUMAN); VON WILLEBRAND FACTOR
Available from:
CSL BEHRING LTD., ISRAEL
ATC code:
B02BD02
Pharmaceutical form:
אבקה וממס להכנת תמיסה להזרקה\אינפוזיה
Composition:
FACTOR VIII (HUMAN) 250 IU / 5 ML; VON WILLEBRAND FACTOR 600 IU / 5 ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
CSL BEHRING GMBH, GERMANY
Therapeutic group:
COAGULATION FACTOR VIII
Therapeutic area:
COAGULATION FACTOR VIII
Therapeutic indications:
Congenital and acquired deficiency of blood clotting factor VIII: severe or moderate haemophilia, prophylaxis during operation, Von Willebrand's disease.
Authorization date:
2014-02-28
